Lichenoid drug eruption

Specialty
Dermatology · Inflammatory skin diseases
Images
Clinical 3
In the app
4 flashcards
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (3)
  2. Definition
  3. Occurrence & epidemiology
  4. Diagnosis
  5. Differential diagnoses
  6. Treatment principles
  7. Keep learning in the app
  8. References (selection)
  9. Cross-references

Images (3)

Lichenoid drug eruption – clinical photo: Chest: multiple shiny, violaceous, slightly scaly papules and plaques, which appeared while the patient was taking a statin-containing combination product (cholesterol-lowering drug)
Chest: multiple shiny, violaceous, slightly scaly papules and plaques, which appeared while the patient was taking a statin-containing combination product (cholesterol-lowering drug)Navarro-Triviño FJ, Ruiz-Villaverde R (An Bras Dermatol 2023), CC BY 4.0, via PubMed Central (PMC9837629) – panel A (cropped) · CC BY 4.0 · Source
Lichenoid drug eruption – clinical photo: Neckline (A) and lower legs (B): erythematous to violaceous papules and plaques, some hypertrophic, during immune checkpoint inhibitor therapy
Neckline (A) and lower legs (B): erythematous to violaceous papules and plaques, some hypertrophic, during immune checkpoint inhibitor therapyLeme HJ, Ramos J, Magarreiro-Silva A, Gouveia A, Alves J (Cureus 2025), CC BY 4.0, via PubMed Central (PMC12296375) · CC BY 4.0 · Source
Lichenoid drug eruption – AI illustration (not a patient photo): trunk-predominant pruritic lichenoid papules (45-year-old man, back/forearms)AI illustration
trunk-predominant pruritic lichenoid papules (45-year-old man, back/forearms)AI-generated illustration for teaching purposes – not a real patient photo.
1 / 3

Definition

Lichenoid drug eruption is an uncommon rash that can be induced by medicines, but also by environmental agents or industrial by-products. Clinically and histologically it resembles idiopathic lichen planus and can be difficult to distinguish from it.

  • Differentiation from classic LP:
  • Predilection sites: Different from classic LP (e.g., trunk, extensor surfaces)
  • Wickham's striae: Usually absent, mucosa rarely involved
  • Common Triggers: NSAIDs, antimalarials, beta-blockers.
  • Clinical presentation: Trunk-predominant lichenoid, itchy papules.
  • Histology: band-like lymphocytic infiltrate at the dermo-epidermal junction, Civatte bodies.

Occurrence & epidemiology

The latent period between starting the drug and the rash is generally 2–3 months, sometimes more than one year; the eruption may even appear after the drug is no longer taken. This makes it challenging to identify the culprit drug.

Diagnosis

  • Suspected from the unusual features (extensive symmetrical distribution, photodistribution, absent Wickham striae, uncommon mucosal and nail involvement), then skin biopsy.
  • Detailed history of all medicines taken in the preceding year, including those taken only briefly or once.

Differential diagnoses

Image credits for the thumbnails
  • Lichen planus: James Heilman, MD, “Lichen Planus (2)”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Pityriasis rosea: Aceofhearts1968, “Pityriasis rosea-1”, Public Domain, via Wikimedia Commons · Public domain · Source
  • Mycosis fungoides: Wikindrea, “Mycosis Fungoides Before Sun and Cartamo”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Secondary syphilis (lues II): Ehlers S, Sergent S, Ashurst J (Clin Pract Cases Emerg Med 2020), CC BY 4.0, via PubMed Central (PMC7676796) · CC BY 4.0 · Source
  • PLEVA (Pityriasis lichenoides et varioliformis acuta): Florian Jesse, “PLEVA”, Public domain, via Wikimedia Commons · Public domain · Source
  • Pityriasis lichenoides chronica (PLC): Ahmed HB, Aziz JMA, Salih MKB et al. (Clin Case Rep 2026), CC BY 4.0, via PubMed Central (PMC13478903) · CC BY 4.0 · Source
  • Graft-versus-host disease (GvHD): Choi E, Nguyen CV (JAAD Case Rep 2024), CC BY 4.0, via PubMed Central (PMC11403442) · CC BY 4.0 · Source
  • Lichen nitidus: Belda W, Criado PR, Di Chiacchio NG (An Bras Dermatol 2021), CC BY 4.0, via PubMed Central (PMC8178568) · CC BY 4.0 · Source

Treatment principles

  • The key step is withdrawing the causative drug; resolution is often delayed over weeks to months, frequently with post-inflammatory hyperpigmentation.
  • Localised disease is treated with topical glucocorticoids, itch with oral antihistamines, and extensive eruptions without features of a severe cutaneous adverse reaction with short-term systemic glucocorticoids.
  • An allergy passport and information about possible cross-reactions are part of management.

Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.

Keep learning in the app

In the DermaFuchs app you can learn Lichenoid drug eruption with flashcards, exam questions and spot-the-diagnosis – free, in your browser or as an app.

Test yourself: Spot-diagnosis quiz with real cases →

In the app: 4 flashcards

Open in browser  Download on the App Store

References (selection)

  1. Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications
  2. DermNet: Lichenoid drug eruption

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the DermaFuchs app – free, in your browser or as an app.

Related pages: Lichen planus · Pityriasis rosea · Mycosis fungoides

Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.